Subject: Autism Spectrum Disorders: From Biological Understanding to Therapeutic Strategies
div, p, a, li, td { -webkit-text-size-adjust:none; }
Roche - Nature Medicine
Translational Neuroscience Symposium 2012
Autism Spectrum Disorders: From Biological Understanding to
Therapeutic Strategies
The
fourth edition of Roche - Nature Medicine Translational
Neuroscience Symposium aims at bringing together the world's most
distinguished scientists and academics in the areas of autism and
neurodevelopmental disorders to share their latest work with each
other and around 40 members of Roche's Neuroscience team. Recent
genomic and functional studies have shed light on the pathophysiology
of autism. The objectives of this meeting are to discuss these recent
advances and to explore how insights from other developmental brain
disorders can illuminate our quest to understand the biological basis
of autism.
SPEAKERS: Gus Alusi
Patrick Bolton
Thomas Bourgeron
Susan Brookheimer
Randall Carpenter
John Constantino
Jacqueline Crawley
Karl Deisseroth
Evan Eichler
Daniel Geschwind
Alysson Muotri
Declan Murphy Kevin Pelphrey
Martin Raff
Mustafa Sahin
Matthew State
Thomas Sudhof
Mehmet Fatih Yanik
SCIENTIFIC
COMMITTEE
Eva Chmielnicki (Nature
Medicine, USA)
Paulo Fontoura (Roche Neuroscience, Switzerland
)
Daniel Geschwind (University of California, Los Angeles School
of Medicine, USA)
Anirvan Ghosh (Roche Neuroscience, Switzerland )
Thomas R. Insel (National Institute of Mental Health, National
Institutes of Health, USA)
Juan Carlos Lopez (Nature Medicine, USA)
Luca Santarelli (Roche Neuroscience, Switzerland)
Will Spooren (Roche Neuroscience,
Switzerland)
© 2012 Nature Publishing Group, a division of Macmillan Publishers
Limited. All rights reserved.